Sriparesh Formulations Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
- Paid Up Capital ₹ 2.95 Cr
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Revenue Growth -6.08%
- Profit Growth -10.57%
- Ebitda 14.76%
- Net Worth 0.37%
- Total Assets 7.40%
About Sriparesh Formulations
Sriparesh Formulations Private Limited (SFPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 December 2015 (Nine years and two months 2 days old ). Its registered office is in Karimnagar, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 2.95 Cr.
The company currently has active open charges totaling ₹4.00 M.
Srinivasreddy Dhava, Raparla Krishna, Thummala Reddy, and One other member serve as directors at the Company.
Company Details
-
Location
Karimnagar, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TG2015PTC102118
-
Company No.
102118
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Dec 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sriparesh Formulations?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasreddy Dhava
|
Director | 31-Jan-2022 | Current |
|
Raparla Krishna
|
Director | 08-Dec-2015 | Current |
|
Thummala Reddy
|
Director | 08-Dec-2015 | Current |
Dhulipalla Kumar
|
Director | 17-Sep-2021 | Current |
Financial Performance of Sriparesh Formulations.
Sriparesh Formulations Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.08% decrease. The company also saw a substantial fall in profitability, with a 10.57% decrease in profit. The company's net worth moved up by a moderate rise of 0.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sriparesh Formulations?
In 2023, Sriparesh Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Farmrobo Technologies Private LimitedDhulipalla Kumar is a mutual person
-
Kartikeya First Care Private Limited
Dhulipalla Kumar is a mutual person
Charges (Loans)
₹0.40 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jun 2018 | Others | ₹4.00 M | Open |
How Many Employees Work at Sriparesh Formulations?
Unlock and access historical data on people associated with Sriparesh Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sriparesh Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sriparesh Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.